Location History:
- Sao Mamede Escariz, PT (2021)
- Säo Mamede Escariz, PT (2022)
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2021-2022
Title: Cristina Correia: Innovator in Gellan Gum Hydrogels
Introduction
Cristina Correia is a prominent inventor based in Säo Mamede Escariz, Portugal. She has made significant contributions to the field of regenerative medicine through her innovative work on gellan gum-based hydrogels. With a total of 2 patents, her research focuses on applications that enhance cell culture and tissue engineering.
Latest Patents
Cristina's latest patents include the development of gellan gum hydrogels, which are designed for in vitro cell culture and tissue engineering applications. These hydrogels can be utilized alone or in combination with live cells and biomolecules for applications in both humans and animals. The chemical modification of gellan gum with selected ion-chelating substituents results in novel hydrogels that possess tunable physicochemical and biological properties. These modified hydrogels offer several advantages over existing systems, such as improved solubility, versatility in ionic crosslinking, ease of formulation, injectability, and enhanced adhesiveness to biological tissues. They also maintain the viability of encapsulated cells during extended culture periods and promote the expression of healthy extracellular matrix markers.
Another significant patent involves gellan gum-based hydrogels aimed at promoting chondrogenic, osteogenic, and adipogenic differentiation of human mesenchymal stem cells, with a particular focus on osteogenic differentiation. This patent outlines a composition intended for use in bone, cartilage, and soft tissue engineering, with a preference for applications in bone.
Career Highlights
Cristina has worked with notable companies in the field, including Stemmatters and Biotecnologia e Medicina Regenerativa. Her work has been instrumental in advancing the understanding and application of gellan gum in regenerative medicine.
Collaborations
Cristina has collaborated with esteemed colleagues such as Rui Pedro Romero Amandi De Sousa and David Alexander Learmonth, contributing to the advancement of research in her field.
Conclusion
Cristina Correia's innovative work in gellan gum hydrogels represents a significant advancement in regenerative medicine. Her patents and collaborations highlight her commitment to improving tissue engineering applications. Through her research, she continues to pave the way for future innovations in the field.